Stefanie Keil

561 total citations
11 papers, 477 citations indexed

About

Stefanie Keil is a scholar working on Molecular Biology, Organic Chemistry and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Stefanie Keil has authored 11 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Stefanie Keil's work include Glycosylation and Glycoproteins Research (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Stefanie Keil is often cited by papers focused on Glycosylation and Glycoproteins Research (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Peroxisome Proliferator-Activated Receptors (3 papers). Stefanie Keil collaborates with scholars based in Germany, France and Switzerland. Stefanie Keil's co-authors include Horst Kunz, C. Claus, Wolfgang Dippold, Martin Bossart, Torsten Haack, Philip J. Larsen, Michael Wagner, Maximilian Posch, Frank Wagner and Lenore Teichert and has published in prestigious journals such as Angewandte Chemie International Edition, PEDIATRICS and Endocrinology.

In The Last Decade

Stefanie Keil

11 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Keil Germany 9 322 159 157 85 75 11 477
Edward J. Brady United States 11 278 0.9× 147 0.9× 58 0.4× 53 0.6× 104 1.4× 13 443
Per Olaf Huusfeldt Denmark 9 423 1.3× 434 2.7× 128 0.8× 39 0.5× 247 3.3× 11 793
David H. Singleton United States 10 449 1.4× 48 0.3× 200 1.3× 21 0.2× 33 0.4× 12 755
Barbara J. Palazuk United States 10 421 1.3× 76 0.5× 71 0.5× 219 2.6× 63 0.8× 10 683
Amanda Ferguson United States 5 345 1.1× 52 0.3× 91 0.6× 55 0.6× 51 0.7× 7 499
Jim D. Durbin United States 11 239 0.7× 63 0.4× 96 0.6× 33 0.4× 109 1.5× 16 445
Martin Bossart Germany 17 270 0.8× 333 2.1× 461 2.9× 74 0.9× 148 2.0× 27 958
Debra L. Ondeyka United States 7 232 0.7× 80 0.5× 120 0.8× 25 0.3× 46 0.6× 9 443
Changyou Zhou United States 15 300 0.9× 107 0.7× 179 1.1× 15 0.2× 98 1.3× 25 505
Larissa Wilsie United States 10 162 0.5× 45 0.3× 71 0.5× 83 1.0× 84 1.1× 10 428

Countries citing papers authored by Stefanie Keil

Since Specialization
Citations

This map shows the geographic impact of Stefanie Keil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Keil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Keil more than expected).

Fields of papers citing papers by Stefanie Keil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Keil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Keil. The network helps show where Stefanie Keil may publish in the future.

Co-authorship network of co-authors of Stefanie Keil

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Keil. A scholar is included among the top collaborators of Stefanie Keil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Keil. Stefanie Keil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Elvert, Ralf, Andreas W. Herling, Martin Bossart, et al.. (2018). Running on mixed fuel‐dual agonistic approach of GLP‐1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non‐human primates. Diabetes Obesity and Metabolism. 20(8). 1836–1851. 30 indexed citations
2.
Tillner, J., Maximilian Posch, Frank Wagner, et al.. (2018). A novel dual glucagon‐like peptide and glucagon receptor agonist SAR425899: Results of randomized, placebo‐controlled first‐in‐human and first‐in‐patient trials. Diabetes Obesity and Metabolism. 21(1). 120–128. 135 indexed citations
3.
Elvert, Ralf, Martin Bossart, Andreas W. Herling, et al.. (2018). Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys. Endocrinology. 159(8). 3105–3119. 19 indexed citations
4.
Zöller, G., Hans Matter, Andreas W. Herling, et al.. (2013). Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1). European Journal of Pharmacology. 707(1-3). 140–146. 10 indexed citations
5.
Keil, Stefanie, Francjan J. van Spronsen, Nilo Lambruschini, et al.. (2013). Long-term Follow-up and Outcome of Phenylketonuria Patients on Sapropterin: A Retrospective Study. PEDIATRICS. 131(6). e1881–e1888. 61 indexed citations
6.
Keil, Stefanie, Hans Matter, Karl Schönafinger, et al.. (2011). Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator‐Activated Receptor (PPAR) γ/δ Agonists with High Potency and in vivo Efficacy. ChemMedChem. 6(4). 633–653. 17 indexed citations
7.
Keil, Stefanie, Marco Müller, G. Zöller, et al.. (2010). Identification and Synthesis of Novel Inhibitors of Acetyl-CoA Carboxylase with in Vitro and in Vivo Efficacy on Fat Oxidation. Journal of Medicinal Chemistry. 53(24). 8679–8687. 26 indexed citations
8.
Kunz, Horst, et al.. (2009). Dendrimers of Vaccines Consisting of Tumor-Associated Glycopeptide Antigens and T Cell Epitope Peptides. Synthesis. 2009(8). 1355–1369. 5 indexed citations
9.
Keil, Stefanie, C. Claus, Wolfgang Dippold, & Horst Kunz. (2001). Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin Epitope. Angewandte Chemie International Edition. 40(2). 366–369. 107 indexed citations
10.
Keil, Stefanie, C. Claus, Wolfgang Dippold, & Horst Kunz. (2001). Zur Entwicklung von Antitumor-Impfstoffen: ein synthetisches Konjugat aus tumorassoziiertem MUC1-Glycopeptidantigen und dem Tetanustoxin-Epitop. Angewandte Chemie. 113(2). 379–382. 61 indexed citations
11.
Keil, Stefanie, C. Claus, Wolfgang Dippold, & Horst Kunz. (2001). Towards the Development of Antitumor Vaccines: A Synthetic Conjugate of a Tumor-Associated MUC1 Glycopeptide Antigen and a Tetanus Toxin Epitope This work was supported by the Deutsche Forschungsgemeinschaft and by the Stiftung Rheinland-Pfalz für Innovation. S.K. is grateful for a Kekulé-Stipendium from the Fonds der Chemischen Industrie.. PubMed. 40(2). 366–369. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026